Clinical Trial Results:
            Avastin / Irinotecan in patients with recurrent or progressive malignant glioma
An academic prospective single-arm phase II clinical trial for evaluation of advanced functional neuroimaging techniques and molecular markers in the course of anti-angiogenic therapies in malignant gliomas
    
|     Summary | |
|     EudraCT number | 2009-015036-15 | 
|     Trial protocol | AT | 
|     Global completion date | |
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | |
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | |
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | |
|     Results information | |
|     Results version number | v1(current) | 
|     This version publication date | 
                                    27 Jan 2017
                             | 
|     First version publication date | 
                                    27 Jan 2017
                             | 
|     Other versions | |
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
